Page last updated: 2024-08-17

quinoxalines and byl719

quinoxalines has been researched along with byl719 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dalianis, T; Herold, N; Holzhauser, S; Kostopoulou, ON; Lukoseviciute, M; Papachristofi, C; Vasilopoulou, C; Wickström, M	1

Other Studies

1 other study(ies) available for quinoxalines and byl719

Article	Year
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines. International journal of oncology, 2021, Volume: 58, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Cisplatin; Cytostatic Agents; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Neuroblastoma; Phosphoinositide-3 Kinase Inhibitors; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Thiazoles; Vincristine	2021

Article

Year

Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.

International journal of oncology, 2021, Volume: 58, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Cisplatin; Cytostatic Agents; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Neuroblastoma; Phosphoinositide-3 Kinase Inhibitors; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Thiazoles; Vincristine

2021